AIG, CRWE, EGN, CLDX - Stock-PR.com Stock Highlights! American International Group, Crown Equity Holdings, Energen Corporation, Celldex Therapeutics
FREE Daily Stock Alerts From Stock-PR.com American International Group, Inc. (NYSE:AIG) reported that Peter D. Hancock, Chief Executive Officer of Chartis, AIG's global property casualty business, is scheduled to present at the Deutsche Bank 2012 Global Financial Services Investor Conference on Monday, May 21, 2012 at 10:20 a.m. ET. ***************** Crown Equity Holdings Inc. (CRWE.OB) Crown Equity Holdings Inc. (CRWE) has previously launched a new online service companies CRWE Real Estate. Crown Equity Holdings Inc. launched CRWE Real Estate to provide a global portal for property listings at a fee of only $1 a day. CRWE Real Estate mission is to empower consumers with information and tools to make smart decisions about homes, real estate and mortgages. Crown Equity Holdings Inc. offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. CRWE advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. For more information about CRWE Real Estate please visit http://www.crwerealestate.com For more information about Crown Equity Holdings Inc. please visit http://www.crownequityholdings.com ***************** Energen Corporation (NYSE:EGN) senior managers will meet with members of the investment communities in Atlanta, Dallas, and Houston on May 21-23, 2012. Associated meeting materials will be available for viewing on Energen's home page, beginning Monday, May 21, at 8:00 a.m. ET. ***************** Celldex Therapeutics, Inc. (Nasdaq:CLDX) will host a conference call at 4:30 P.M. Eastern Time on Wednesday, May 23, 2012 to announce interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer. Linda Vahdat, MD, Professor of Medicine, Chief of Solid Tumor Service and Director of the Breast Cancer Research Program at Weill Cornell Medical College and the lead investigator of the EMERGE study, will join Celldex management on the webcast to discuss data from the study. ************************************************************** THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company.Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Sign Up For Free Stock Alerts At http://stock-pr.com/signup